Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

Kinoshita Toshihiko; Bai Ya-Mei; Kim Jong-Hoon; Miyake Mutsuo; Oshima Nobuyuki

首页> 外文期刊>Psychopharmacology >Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

【24h】

Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

机译：阿塞那平在亚洲精神分裂症急性加重患者中的疗效和安全性：一项多中心，随机，双盲，6周，安慰剂对照研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Asenapine is a second generation anti-psychotic approved in the USA in 2009 for the treatment of schizophrenia, but its efficacy has not been proven in Asian patients.

机译：阿塞那平是2009年在美国批准用于治疗精神分裂症的第二代抗精神病药，但尚未在亚洲患者中证明其功效。

著录项

来源
《Psychopharmacology》 |2016年第14期|共12页
作者
Kinoshita Toshihiko; Bai Ya-Mei; Kim Jong-Hoon; Miyake Mutsuo; Oshima Nobuyuki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Schizophrenia; Asenapine; Efficacy; Tolerability;

机译：精神分裂症;阿塞那平;功效;耐受性;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study [J] . Kinoshita Toshihiko, Bai Ya-Mei, Kim Jong-Hoon, Psychopharmacology . 2016,第14期

机译：阿塞那平在亚洲精神分裂症急性加重患者中的疗效和安全性：一项多中心，随机，双盲，6周，安慰剂对照研究
2. Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study. [J] . Casey DE, Sands EE, Heisterberg J, Psychopharmacology . 2008,第3期

机译：贝非诺酮对精神分裂症急性加重患者的疗效和安全性：一项随机，双盲，安慰剂对照，多中心，剂量研究的结果。
3. Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study [J] . Daniel E. Casey, Earl E. Sands, Jens Heisterberg, Psychopharmacology . 2008,第3期

机译：贝非诺酮对精神分裂症急性加重患者的疗效和安全性：一项随机，双盲，安慰剂对照，多中心，剂量研究的结果
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre randomized double-blind 6-week placebo-controlled study [O] . Toshihiko Kinoshita, Ya-Mei Bai, Jong-Hoon Kim, -1

机译：阿塞那平在亚洲精神分裂症急性加重患者中的疗效和安全性：一项多中心随机双盲6周安慰剂对照研究
7. Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study [O] . Toshihiko Kinoshita, Ya-Mei Bai, Jong-Hoon Kim, 2016

机译：阿塞那平在亚洲精神分裂症急性加重患者中的疗效和安全性：一项多中心，随机，双盲，6周，安慰剂对照研究

Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study

摘要

著录项

相似文献

相关主题

期刊订阅